APA-viite

Nissen, S. E., Dent‐Acosta, R. E., Rosenson, R. S., Stroes, E., Sattar, N., Preiss, D., . . . Thompson, P. D. (2016). Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin‐Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti‐PCSK9 Antibody in Statin‐Intolerant Subjects 3 (GAUSS‐3) Trial. Clin Cardiol.

Chicago-tyylinen lähdeviittaus

Nissen, Steven E., et al. "Comparison of PCSK9 Inhibitor Evolocumab Vs Ezetimibe in Statin‐Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti‐PCSK9 Antibody in Statin‐Intolerant Subjects 3 (GAUSS‐3) Trial." Clin Cardiol 2016.

MLA-viite

Nissen, Steven E., et al. "Comparison of PCSK9 Inhibitor Evolocumab Vs Ezetimibe in Statin‐Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti‐PCSK9 Antibody in Statin‐Intolerant Subjects 3 (GAUSS‐3) Trial." Clin Cardiol 2016.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.